Antiprotozoal Drugs Market Size, Share, Growth, and Industry Analysis, By Type (Amoebic Dysentery, Antimalarial Drug, Leishmaniasis & Chagas Disease, Metronidazole, Atovaquone, Benznidazole, Dehydroemetine, Eflornithine, Emetine, Fenbendazole, Iodoquinol, Melarsoprol, Others (like Meglumine antimonite, Nifurtimox, Pentamidine, etc.)), By Application (Hospital, Clinic), Regional Insights and Forecast to 2033

Detailed TOC of Global and United States Antiprotozoal Drugs Market Report & Forecast 2022-2028

1 Study Coverage
1.1 Antiprotozoal Drugs Revenue in Antiprotozoal Drugs Business (2017-2022) & (US$ Million) Introduction
1.2 Global Antiprotozoal Drugs Outlook 2017 VS 2022 VS 2028
1.2.1 Global Antiprotozoal Drugs Market Size for the Year 2017-2028
1.2.2 Global Antiprotozoal Drugs Market Size for the Year 2017-2028
1.3 Antiprotozoal Drugs Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.3.1 The Market Share of United States Antiprotozoal Drugs in Global, 2017 VS 2022 VS 2028
1.3.2 The Growth Rate of Antiprotozoal Drugs Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4 Antiprotozoal Drugs Market Dynamics
1.4.1 Antiprotozoal Drugs Industry Trends
1.4.2 Antiprotozoal Drugs Market Drivers
1.4.3 Antiprotozoal Drugs Market Challenges
1.4.4 Antiprotozoal Drugs Market Restraints
1.5 Study Objectives
1.6 Years Considered
2 Antiprotozoal Drugs by Type
2.1 Antiprotozoal Drugs Market Segment by Type
2.1.1 Amoebic Dysentery
2.1.2 Antimalarial Drug
2.1.3 Leishmaniasis & Chagas Disease
2.2 Global Antiprotozoal Drugs Market Size by Type (2017, 2022 & 2028)
2.3 Global Antiprotozoal Drugs Market Size by Type (2017-2028)
2.4 United States Antiprotozoal Drugs Market Size by Type (2017, 2022 & 2028)
2.5 United States Antiprotozoal Drugs Market Size by Type (2017-2028)
3 Antiprotozoal Drugs by Application
3.1 Antiprotozoal Drugs Market Segment by Application
3.1.1 Hospital
3.1.2 Clinic
3.2 Global Antiprotozoal Drugs Market Size by Application (2017, 2022 & 2028)
3.3 Global Antiprotozoal Drugs Market Size by Application (2017-2028)
3.4 United States Antiprotozoal Drugs Market Size by Application (2017, 2022 & 2028)
3.5 United States Antiprotozoal Drugs Market Size by Application (2017-2028)
4 Global Antiprotozoal Drugs Competitor Landscape by Company
4.1 Global Antiprotozoal Drugs Market Size by Company
4.1.1 Top Global Antiprotozoal Drugs Companies Ranked by Revenue (2021)
4.1.2 Global Antiprotozoal Drugs Revenue by Player (2017-2022)
4.2 Global Antiprotozoal Drugs Concentration Ratio (CR)
4.2.1 Antiprotozoal Drugs Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Companies of Antiprotozoal Drugs in 2021
4.2.3 Global Antiprotozoal Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Antiprotozoal Drugs Headquarters, Revenue in Antiprotozoal Drugs Business (2017-2022) & (US$ Million) Type
4.3.1 Global Antiprotozoal Drugs Headquarters and Area Served
4.3.2 Global Antiprotozoal Drugs Companies Revenue in Antiprotozoal Drugs Business (2017-2022) & (US$ Million) Type
4.3.3 Date of International Companies Enter into Antiprotozoal Drugs Market
4.4 Companies Mergers & Acquisitions, Expansion Plans
4.5 United States Antiprotozoal Drugs Market Size by Company
4.5.1 Top Antiprotozoal Drugs Players in United States, Ranked by Revenue (2021)
4.5.2 United States Antiprotozoal Drugs Revenue by Players (2020, 2021 & 2022)
5 Global Antiprotozoal Drugs Market Size by Region
5.1 Global Antiprotozoal Drugs Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Antiprotozoal Drugs Market Size by Region (2017-2028)
5.2.1 Global Antiprotozoal Drugs Market Size by Region: 2017-2022
5.2.2 Global Antiprotozoal Drugs Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Antiprotozoal Drugs Market Size YoY Growth 2017-2028
6.1.2 North America Antiprotozoal Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Antiprotozoal Drugs Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Antiprotozoal Drugs Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Antiprotozoal Drugs Market Size YoY Growth 2017-2028
6.3.2 Europe Antiprotozoal Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Antiprotozoal Drugs Market Size YoY Growth 2017-2028
6.4.2 Latin America Antiprotozoal Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Antiprotozoal Drugs Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Antiprotozoal Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 UAE
7 Company Profiles
7.1 Sanofi
7.1.1 Sanofi Company Details
7.1.2 Sanofi Business Overview
7.1.3 Sanofi Antiprotozoal Drugs Introduction
7.1.4 Sanofi Revenue in Antiprotozoal Drugs Business (2017-2022)
7.1.5 Sanofi Recent Development
7.2 Akthelia Pharmaceuticals Ltd
7.2.1 Akthelia Pharmaceuticals Ltd Company Details
7.2.2 Akthelia Pharmaceuticals Ltd Business Overview
7.2.3 Akthelia Pharmaceuticals Ltd Antiprotozoal Drugs Introduction
7.2.4 Akthelia Pharmaceuticals Ltd Revenue in Antiprotozoal Drugs Business (2017-2022)
7.2.5 Akthelia Pharmaceuticals Ltd Recent Development
7.3 GlaxoSmithKline Plc
7.3.1 GlaxoSmithKline Plc Company Details
7.3.2 GlaxoSmithKline Plc Business Overview
7.3.3 GlaxoSmithKline Plc Antiprotozoal Drugs Introduction
7.3.4 GlaxoSmithKline Plc Revenue in Antiprotozoal Drugs Business (2017-2022)
7.3.5 GlaxoSmithKline Plc Recent Development
7.4 Immuron Ltd
7.4.1 Immuron Ltd Company Details
7.4.2 Immuron Ltd Business Overview
7.4.3 Immuron Ltd Antiprotozoal Drugs Introduction
7.4.4 Immuron Ltd Revenue in Antiprotozoal Drugs Business (2017-2022)
7.4.5 Immuron Ltd Recent Development
7.5 Microbiotix Inc
7.5.1 Microbiotix Inc Company Details
7.5.2 Microbiotix Inc Business Overview
7.5.3 Microbiotix Inc Antiprotozoal Drugs Introduction
7.5.4 Microbiotix Inc Revenue in Antiprotozoal Drugs Business (2017-2022)
7.5.5 Microbiotix Inc Recent Development
7.6 Protein Potential LLC
7.6.1 Protein Potential LLC Company Details
7.6.2 Protein Potential LLC Business Overview
7.6.3 Protein Potential LLC Antiprotozoal Drugs Introduction
7.6.4 Protein Potential LLC Revenue in Antiprotozoal Drugs Business (2017-2022)
7.6.5 Protein Potential LLC Recent Development
7.7 Dr. Reddy?s Laboratories
7.7.1 Dr. Reddy?s Laboratories Company Details
7.7.2 Dr. Reddy?s Laboratories Business Overview
7.7.3 Dr. Reddy?s Laboratories Antiprotozoal Drugs Introduction
7.7.4 Dr. Reddy?s Laboratories Revenue in Antiprotozoal Drugs Business (2017-2022)
7.7.5 Dr. Reddy?s Laboratories Recent Development
7.8 Mission Pharmacal
7.8.1 Mission Pharmacal Company Details
7.8.2 Mission Pharmacal Business Overview
7.8.3 Mission Pharmacal Antiprotozoal Drugs Introduction
7.8.4 Mission Pharmacal Revenue in Antiprotozoal Drugs Business (2017-2022)
7.8.5 Mission Pharmacal Recent Development
7.9 Aceto Corp.
7.9.1 Aceto Corp. Company Details
7.9.2 Aceto Corp. Business Overview
7.9.3 Aceto Corp. Antiprotozoal Drugs Introduction
7.9.4 Aceto Corp. Revenue in Antiprotozoal Drugs Business (2017-2022)
7.9.5 Aceto Corp. Recent Development
7.10 Mylan Pharmaceuticals
7.10.1 Mylan Pharmaceuticals Company Details
7.10.2 Mylan Pharmaceuticals Business Overview
7.10.3 Mylan Pharmaceuticals Antiprotozoal Drugs Introduction
7.10.4 Mylan Pharmaceuticals Revenue in Antiprotozoal Drugs Business (2017-2022)
7.10.5 Mylan Pharmaceuticals Recent Development
7.11 Impax Laboratories
7.11.1 Impax Laboratories Company Details
7.11.2 Impax Laboratories Business Overview
7.11.3 Impax Laboratories Antiprotozoal Drugs Introduction
7.11.4 Impax Laboratories Revenue in Antiprotozoal Drugs Business (2017-2022)
7.11.5 Impax Laboratories Recent Development
7.12 Pfizer
7.12.1 Pfizer Company Details
7.12.2 Pfizer Business Overview
7.12.3 Pfizer Antiprotozoal Drugs Introduction
7.12.4 Pfizer Revenue in Antiprotozoal Drugs Business (2017-2022)
7.12.5 Pfizer Recent Development
7.13 Lupin Pharmaceuticals
7.13.1 Lupin Pharmaceuticals Company Details
7.13.2 Lupin Pharmaceuticals Business Overview
7.13.3 Lupin Pharmaceuticals Antiprotozoal Drugs Introduction
7.13.4 Lupin Pharmaceuticals Revenue in Antiprotozoal Drugs Business (2017-2022)
7.13.5 Lupin Pharmaceuticals Recent Development
7.14 Glenmark Pharmaceuticals
7.14.1 Glenmark Pharmaceuticals Company Details
7.14.2 Glenmark Pharmaceuticals Business Overview
7.14.3 Glenmark Pharmaceuticals Antiprotozoal Drugs Introduction
7.14.4 Glenmark Pharmaceuticals Revenue in Antiprotozoal Drugs Business (2017-2022)
7.14.5 Glenmark Pharmaceuticals Recent Development
7.15 Sun Pharmaceutical
7.15.1 Sun Pharmaceutical Company Details
7.15.2 Sun Pharmaceutical Business Overview
7.15.3 Sun Pharmaceutical Antiprotozoal Drugs Introduction
7.15.4 Sun Pharmaceutical Revenue in Antiprotozoal Drugs Business (2017-2022)
7.15.5 Sun Pharmaceutical Recent Development
7.16 Heritage Pharmaceuticals
7.16.1 Heritage Pharmaceuticals Company Details
7.16.2 Heritage Pharmaceuticals Business Overview
7.16.3 Heritage Pharmaceuticals Antiprotozoal Drugs Introduction
7.16.4 Heritage Pharmaceuticals Revenue in Antiprotozoal Drugs Business (2017-2022)
7.16.5 Heritage Pharmaceuticals Recent Development
7.17 Gilead Sciences
7.17.1 Gilead Sciences Company Details
7.17.2 Gilead Sciences Business Overview
7.17.3 Gilead Sciences Antiprotozoal Drugs Introduction
7.17.4 Gilead Sciences Revenue in Antiprotozoal Drugs Business (2017-2022)
7.17.5 Gilead Sciences Recent Development
7.18 Johnson & Johnson
7.18.1 Johnson & Johnson Company Details
7.18.2 Johnson & Johnson Business Overview
7.18.3 Johnson & Johnson Antiprotozoal Drugs Introduction
7.18.4 Johnson & Johnson Revenue in Antiprotozoal Drugs Business (2017-2022)
7.18.5 Johnson & Johnson Recent Development
7.19 Bristol-Myers Squibb
7.19.1 Bristol-Myers Squibb Company Details
7.19.2 Bristol-Myers Squibb Business Overview
7.19.3 Bristol-Myers Squibb Antiprotozoal Drugs Introduction
7.19.4 Bristol-Myers Squibb Revenue in Antiprotozoal Drugs Business (2017-2022)
7.19.5 Bristol-Myers Squibb Recent Development
7.20 Profounda
7.20.1 Profounda Company Details
7.20.2 Profounda Business Overview
7.20.3 Profounda Antiprotozoal Drugs Introduction
7.20.4 Profounda Revenue in Antiprotozoal Drugs Business (2017-2022)
7.20.5 Profounda Recent Development
7.21 Knight Therapeutics
7.21.1 Knight Therapeutics Company Details
7.21.2 Knight Therapeutics Business Overview
7.21.3 Knight Therapeutics Antiprotozoal Drugs Introduction
7.21.4 Knight Therapeutics Revenue in Antiprotozoal Drugs Business (2017-2022)
7.21.5 Knight Therapeutics Recent Development
7.22 Albert David
7.22.1 Albert David Company Details
7.22.2 Albert David Business Overview
7.22.3 Albert David Antiprotozoal Drugs Introduction
7.22.4 Albert David Revenue in Antiprotozoal Drugs Business (2017-2022)
7.22.5 Albert David Recent Development
7.23 Wanlong
7.23.1 Wanlong Company Details
7.23.2 Wanlong Business Overview
7.23.3 Wanlong Antiprotozoal Drugs Introduction
7.23.4 Wanlong Revenue in Antiprotozoal Drugs Business (2017-2022)
7.23.5 Wanlong Recent Development
7.24 Fangsheng
7.24.1 Fangsheng Company Details
7.24.2 Fangsheng Business Overview
7.24.3 Fangsheng Antiprotozoal Drugs Introduction
7.24.4 Fangsheng Revenue in Antiprotozoal Drugs Business (2017-2022)
7.24.5 Fangsheng Recent Development
7.25 KPC Pharmaceuticals
7.25.1 KPC Pharmaceuticals Company Details
7.25.2 KPC Pharmaceuticals Business Overview
7.25.3 KPC Pharmaceuticals Antiprotozoal Drugs Introduction
7.25.4 KPC Pharmaceuticals Revenue in Antiprotozoal Drugs Business (2017-2022)
7.25.5 KPC Pharmaceuticals Recent Development
7.26 Guilin Pharmaceuticals
7.26.1 Guilin Pharmaceuticals Company Details
7.26.2 Guilin Pharmaceuticals Business Overview
7.26.3 Guilin Pharmaceuticals Antiprotozoal Drugs Introduction
7.26.4 Guilin Pharmaceuticals Revenue in Antiprotozoal Drugs Business (2017-2022)
7.26.5 Guilin Pharmaceuticals Recent Development
7.27 Pude Pharmaceutica
7.27.1 Pude Pharmaceutica Company Details
7.27.2 Pude Pharmaceutica Business Overview
7.27.3 Pude Pharmaceutica Antiprotozoal Drugs Introduction
7.27.4 Pude Pharmaceutica Revenue in Antiprotozoal Drugs Business (2017-2022)
7.27.5 Pude Pharmaceutica Recent Development
8 Research Findings and Conclusion
9 Appendix
9.1 Research Methodology
9.1.1 Methodology/Research Approach
9.1.2 Data Source
9.2 Author Details
9.3 Disclaimer